Condition: Major Neurocognitive Disorder · Sponsor: CHU de Quebec-Universite Laval
The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home. The goal is to reduce polymedication, inappropriate medications and the treatment burden of seniors and to maintain their cognitive health, quality of life and autonomy. The intervention will include knowledge exchange sessions with nurses, pharmacists, and doctors in FMGs, and increased collaboration between these professionals and home care services teams. Other goal is to increase the satisfaction of the seniors, their families, and the professionals involved in the GPS project.
This description comes directly from the study's public registry record.
Line Guénette, Ph.D · 418-682-7511 · line.guenette@pha.ulaval.ca
Edeltraut Kröger, Ph.D · 418-525-4444 · edeltraut.kroger.ciussscn@ssss.gouv.qc.ca
Always discuss trial participation with your own doctor first.
| GMF Bordeaux-Cartierville | Montreal, Quebec, Canada | Recruiting |
| GMF Abénakis | Saint-Georges, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04889794